AnandRathi

Concord Drugs Ltd Fundamental Analysis

Last Updated Date: 22 Sept 2026
74.00
-0.97 (-1.29%)

Concord Drugs Ltd (Concord Drugs) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹98 crore.

Concord Drugs Ltd Overview

Market cap₹98 Crs
Volume9,775
Prev. Close₹74.97
Year range₹61.00 - ₹92.52
ISININE858L01010

Concord Drugs Ltd Fundamentals

ROCE(TTM)4.82%
P/E Ratio (TTM)47.74
P/B Ratio2.09
Debt to Equity0.24
ROE2.14%
EPS (TTM)1.55
Dividend Yield0.00%
Book Value35.43
Profit Margin2.45%
Operating Margin5.05%

Concord Drugs Ltd Historical Performance

1 Month Return-0.04%
6 Month Return-2.34%
3 Year Return123.46%
3 Month Return-1.52%
1 Year Return11.90%
5 Year Return144.60%

Concord Drugs Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research